Free Trial

Mettler-Toledo International, Inc. $MTD Shares Sold by Walter Public Investments Inc.

Mettler-Toledo International logo with Medical background

Key Points

  • Walter Public Investments Inc. significantly reduced its stake in Mettler-Toledo International by 71.3%, selling 5,587 shares and leaving them with 2,254 shares worth approximately $2.65 million.
  • In Q2, Mettler-Toledo International reported an EPS of $10.09, surpassing estimates and achieving a year-over-year revenue increase of 3.9% to $983.22 million.
  • Analysts have mixed ratings on Mettler-Toledo International, with a consensus target price of $1,311.11, indicating a moderate buy and varied price objectives from different firms.
  • MarketBeat previews the top five stocks to own by October 1st.

Walter Public Investments Inc. lowered its position in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 71.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,254 shares of the medical instruments supplier's stock after selling 5,587 shares during the quarter. Walter Public Investments Inc.'s holdings in Mettler-Toledo International were worth $2,648,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently modified their holdings of the company. WPG Advisers LLC acquired a new position in shares of Mettler-Toledo International during the first quarter worth about $41,000. Zions Bancorporation National Association UT acquired a new position in shares of Mettler-Toledo International during the first quarter worth about $43,000. Golden State Wealth Management LLC lifted its stake in shares of Mettler-Toledo International by 583.3% during the first quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier's stock worth $48,000 after purchasing an additional 35 shares in the last quarter. Menard Financial Group LLC acquired a new position in shares of Mettler-Toledo International during the fourth quarter worth about $67,000. Finally, Blue Trust Inc. lifted its stake in shares of Mettler-Toledo International by 520.0% during the first quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier's stock worth $73,000 after purchasing an additional 52 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company's stock.

Mettler-Toledo International Stock Performance

Shares of NYSE:MTD opened at $1,264.84 on Friday. Mettler-Toledo International, Inc. has a one year low of $946.69 and a one year high of $1,521.01. The stock has a fifty day moving average of $1,264.75 and a 200-day moving average of $1,185.80. The company has a market capitalization of $26.06 billion, a PE ratio of 32.03, a price-to-earnings-growth ratio of 3.80 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The company had revenue of $983.22 million for the quarter, compared to the consensus estimate of $957.41 million. During the same period in the previous year, the business earned $9.65 EPS. The company's revenue was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, research analysts forecast that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have commented on MTD shares. Citigroup boosted their price objective on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a "buy" rating in a research note on Thursday, August 21st. Evercore ISI reduced their price objective on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating on the stock in a research note on Monday, August 4th. Barclays assumed coverage on Mettler-Toledo International in a research note on Tuesday, June 24th. They set an "overweight" rating and a $1,325.00 price objective on the stock. Bank of America boosted their price target on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a "neutral" rating in a research note on Thursday, June 26th. Finally, Robert W. Baird boosted their price target on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a "neutral" rating in a research note on Monday, August 4th. Five research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $1,311.11.

View Our Latest Report on MTD

Insider Transactions at Mettler-Toledo International

In other news, Director Thomas P. Salice sold 1,062 shares of the company's stock in a transaction on Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the transaction, the director directly owned 283 shares of the company's stock, valued at approximately $368,154.70. This represents a 78.96% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Shawn Vadala sold 300 shares of the company's stock in a transaction on Friday, August 8th. The stock was sold at an average price of $1,254.09, for a total transaction of $376,227.00. Following the completion of the transaction, the chief financial officer directly owned 5,095 shares in the company, valued at $6,389,588.55. This trade represents a 5.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 1,827 shares of company stock valued at $2,371,208. 1.94% of the stock is owned by insiders.

Mettler-Toledo International Company Profile

(Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Featured Articles

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTD - Free Report).

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Mettler-Toledo International Right Now?

Before you consider Mettler-Toledo International, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.

While Mettler-Toledo International currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.